Cleveland Clinic
I am a physician scientist doing novel research to understand the role of the human microbiome, and its byproducts, in the development of kidney diseases. As a Research Associate of the Stones Research laboratory of the Cleveland Clinic, I am the leader of cross disciplinary research approaches in applying multi omics technologies to human and animal urinary stone disease (USD) studies. The ultimate goal of these investigations is to understand the elusive pathophysiology of the formation of urinary stones for the subsequent development of preventative, diagnostic and therapeutic strategies. Most of my efforts in the last few years have been directed at the identification of potentially pro-lithogenic or anti-lithogenic bacteria in the urinary microbiome, as well as host and bacterial derived biomolecules present in the urine of stone formers potentially involved in the modulation of stone formation metrics. In the last two years, I am working in collaboration with groups with extensive experience in the research of metabolic diseases. The purpose is to gain insights about the potential common origin of disorders like atherosclerosis and USD.
Disclosure information not submitted.
Saturday, April 29, 2023
9:30 AM – 11:30 AM CST